Changes in FOXO and proinflammatory cytokines in the late stage of immobilized fast and slow muscle atrophy

Biomedical Research (Japan)

Volumn 38, Issue 6, 2017, Pages 331-342

  Okamoto, Takeshi ^a   Machida, Shuichi ^b  

^a Tokai University Fukuoka Junior College   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; TRANSCRIPTION FACTOR FKHRL1; TUMOR NECROSIS FACTOR; AUTACOID; BIOLOGICAL MARKER; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FAST MUSCLE; GENE EXPRESSION; IMMOBILIZATION; INFLAMMATION; MALE; MOUSE; MUSCLE ATROPHY; NONHUMAN; PLANTARIS MUSCLE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SLOW MUSCLE; SOLEUS MUSCLE; ANIMAL; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; ORGAN SIZE; PATHOLOGY; SKELETAL MUSCLE; TIME FACTOR;

ANIMALS; BIOMARKERS; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; MALE; MICE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; ORGAN SIZE; RNA, MESSENGER; TIME FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 85038028814     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.38.331     Document Type: Article

References (48)

1. Andrianjafiniony T, Dupre-Aucouturier S, Letexier D, Couchoux H and Desplanches D (2010) Oxidative stress, apoptosis, and proteolysis in skeletal muscle repair after unloading. Am J Physiol Cell Physiol 299, C307-C315.
2. Arden KC and Biggs WH, 3rd (2002) Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling. Arch Biochem Biophys 403, 292-298.
3. Bar-Shai M, Carmeli E, Ljubuncic P and Reznick AZ (2008) Exercise and immobilization in aging animals: the involvement of oxidative stress and NF-kappaB activation. Free Radic Bio Med 44, 202-214.
4. Bertaggia E, Coletto L and Sandri M (2012) Posttranslational modifications control FoxO3 activity during denervation. Am J Physiol Cell Physiol 302, C587-C596.
5. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD and Glass DJ (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708.
6. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
7. Caron AZ, Drouin G, Desrosiers J, Trensz F and Grenier G (2009) A novel hindlimb immobilization procedure for studying skeletal muscle atrophy and recovery in mouse. J Appl Physiol 106, 2049-2059.
8. Dupont-Versteegden EE (2005) Apoptosis in muscle atrophy: relevance to sarcopenia. Exp Gerontol 40, 473-481.
9. Ferreira R, Vitorino R, Neuparth MJ, Appell HJ, Amado F and Duarte JA (2007) Cellular patterns of the atrophic response in murine soleus and gastrocnemius muscles submitted to simulated weightlessness. Eur J Appl Physiol 101, 331-340.
10. Frost RA, Nystrom GJ, Jefferson LS and Lang CH (2007) Hormone, cytokine, and nutritional regulation of sepsisinduced increases in atrogin-1 and MuRF1 in skeletal muscle. Am J Physiol Endocrinol Metab 292, E501-E512.
11. Gomes MD, Lecker SH, Jagoe RT, Navon A and Goldberg AL (2001) Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98, 14440-14445.
12. Guttridge DC, Mayo MW, Madrid LV, Wang CY and Baldwin AS, Jr. (2000) NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289, 2363-2366.
13. Hedrick SM (2009) The cunning little vixen: Foxo and the cycle of life and death. Nat Immunol 10, 1057-1063.
14. Hirose T, Nakazato K, Song H and Ishii N (2008) TGF-beta1 and TNF-alpha are involved in the transcription of type I collagen alpha2 gene in soleus muscle atrophied by mechanical unloading. J Appl Physiol 104, 170-177.
15. Hunter RB, Stevenson E, Koncarevic A, Mitchell-Felton H, Essig DA and Kandarian SC (2002) Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 16, 529-538.
16. Ikemoto M, Nikawa T, Takeda S, Watanabe C, Kitano T, Baldwin KM, Izumi R, Nonaka I, Towatari T, Teshima S, Rokutan K and Kishi K (2001) Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-proteasome pathway. FASEB J 15, 1279-1281.
17. Kamei Y, Miura S, Suzuki M, Kai Y, Mizukami J, Taniguchi T, Mochida K, Hata T, Matsuda J, Aburatani H, Nishino I and Ezaki O (2004) Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 279, 41114-41123.
18. Kang C and Ji LL (2013) Muscle immobilization and remobilization downregulates PGC-1alpha signaling and the mitochondrial biogenesis pathway. J Appl Physiol 115, 1618-1625.
19. Kim DS, Cha HN, Jo HJ, Song IH, Baek SH, Dan JM, Kim YW, Kim JY, Lee IK, Seo JS and Park SY (2015) TLR2 deficiency attenuates skeletal muscle atrophy in mice. Biochem Biophys Res Commun 459, 534-540.
20. Klein D, Kern RM and Sokol RZ (1995) A method for quantification and correction of proteins after transfer to immobilization membranes. Biochem Mol Biol Int 36, 59-66.
21. Krawiec BJ, Frost RA, Vary TC, Jefferson LS and Lang CH (2005) Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis. Am J Physiol Endocrinol Metab 289, E969-E980.
22. Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL and Reid MB (2003) TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 17, 1048-1057.
23. Li YP and Reid MB (2000) NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Physiol 279, R1165-R1170.
24. MacDonald EM, Andres-Mateos E, Mejias R, Simmers JL, Mi R, Park JS, Ying S, Hoke A, Lee SJ and Cohn RD (2014) Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition. Dis Model Mech 7, 471-481.
25. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S and Sandri M (2007) FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6, 458-471.
26. McLoughlin TJ, Smith SM, DeLong AD, Wang H, Unterman TG and Esser KA (2009) FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner. Am J Physiol Cell Physiol 297, C548-C555.
27. Midrio M (2006) The denervated muscle: facts and hypotheses. A historical review. Eur J Appl Physiol 98, 1-21.
28. Mitchell PO and Pavlath GK (2001) A muscle precursor cell-dependent pathway contributes to muscle growth after atrophy. Am J Physiol Cell Physiol 281, C1706-C1715.
29. Moylan JS, Smith JD, Chambers MA, McLoughlin TJ and Reid MB (2008) TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling. Am J Physiol Cell Physsiol 295, C986-C993.
30. Okamoto T, Torii S and Machida S (2011) Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles. J Physiol Sci 61, 537-546.
31. Peterson JM and Guttridge DC (2008) Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention. Int Rev Immunol 27, 375-387.
32. Puig O and Tjian R (2006) Nutrient availability and growth: regulation of insulin signaling by dFOXO/FOXO1. Cell Cycle 5, 503-505.
33. Reed SA, Senf SM, Cornwell EW, Kandarian SC and Judge AR (2011) Inhibition of IkappaB kinase alpha (IKKalpha) or IKKbeta (IKKbeta) plus forkhead box O (Foxo) abolishes skeletal muscle atrophy. Biochem Biophys Res Commun 405, 491-496.
34. Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, Edgerton VR, Lecker SH and Goldberg AL (2007) Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 21, 140-155.
35. Sandri M (2010) Autophagy in skeletal muscle. FEBS Lett 584, 1411-1416.
36. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH and Goldberg AL (2004) Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399-412.
37. Senf SM, Dodd SL and Judge AR (2010) FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70. Am J Physiol Cell Physiol 298, C38-C45.
38. Spate U and Schulze PC (2004) Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care 7, 265-269.
39. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD and Glass DJ (2004) The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14, 395-403.
40. Sugiura T, Abe N, Nagano M, Goto K, Sakuma K, Naito H, Yoshioka T, and Powers SK (2005) Changes in PKB/Akt and calcineurin signaling during recovery in atrophied soleus muscle induced by unloading. Am J Physiol Regul Integr Physiol 288, R1273-R1278.
41. Suzuki N, Motohashi N, Uezumi A, Fukada S, Yoshimura T, Itoyama Y, Aoki M, Miyagoe-Suzuki Y and Takeda S (2007) NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 117, 2468-2476.
42. Taillandier D, Aurousseau E, Meynial-Denis D, Bechet D, Ferrara M, Cottin P, Ducastaing A, Bigard X, Guezennec CY, Schmid HP, et al. (1996) Coordinate activation of lysosomal, Ca2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem J 316, 65-72.
43. Talbert EE, Smuder AJ, Min K, Kwon OS, Szeto HH and Powers SK (2013) Immobilization-induced activation of key proteolytic systems in skeletal muscles is prevented by a mitochondria-targeted antioxidant. J Appl Physiol 115, 529-538.
44. Thomason DB and Booth FW (1990) Atrophy of the soleus muscle by hindlimb unweighting. J Appl Physiol 68, 1-12.
45. Timmons JA, Norrbom J, Scheele C, Thonberg H, Wahlestedt C and Tesch P (2006) Expression profiling following local muscle inactivity in humans provides new perspective on diabetes-related genes. Genomics 87, 165-172.
46. Tzivion G, Dobson M and Ramakrishnan G (2011) FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 1813, 1938-1945.
47. Van Der Heide LP, Hoekman MF and Smidt MP (2004) The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380, 297-309.
48. Zhao J, Zhang Y, Zhao W, Wu Y, Pan J, Bauman WA and Cardozo C (2008) Effects of nandrolone on denervation atrophy depend upon time after nerve transection. Muscle Nerve 37, 42-49.